Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
30.25
+0.15 (0.50%)
May 16, 2025, 9:31 AM - Market open
Twist Bioscience Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Twist Bioscience stock ranges from a low of $33 to a high of $62. The average analyst price target of $49.1 forecasts a 62.31% increase in the stock price over the next year.
Price Target: $49.10 (+62.31%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Twist Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $55 → $48 | Strong Buy | Maintains | $55 → $48 | +58.68% | May 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +65.29% | May 6, 2025 |
| Baird | Baird | Buy Maintains $54 → $44 | Buy | Maintains | $54 → $44 | +45.45% | May 6, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $40 → $33 | Sell | Maintains | $40 → $33 | +9.09% | May 6, 2025 |
| Barclays | Barclays | Buy Maintains $58 → $45 | Buy | Maintains | $58 → $45 | +48.76% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
383.58M
from 312.97M
Increased by 22.56%
Revenue Next Year
451.45M
from 383.58M
Increased by 17.69%
EPS This Year
-2.21
from -3.60
EPS Next Year
-1.71
from -2.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 396.9M | 476.6M | 584.9M | ||
| Avg | 383.6M | 451.5M | 534.5M | ||
| Low | 365.3M | 418.5M | 489.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.8% | 24.3% | 29.5% | ||
| Avg | 22.6% | 17.7% | 18.4% | ||
| Low | 16.7% | 9.1% | 8.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.89 | -1.25 | -0.78 |
| Avg | -2.21 | -1.71 | -1.31 |
| Low | -2.77 | -2.40 | -2.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.